Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Report 2020

QYR625447
122 Pages
July 2016
Diagnostic and Biotech

Download Sample Get Discount

This report studies Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Global and China market, focuses on top manufacturers in global and China market, involving Commercializing Biomarkers in Therapeutic and Diagnostic Applications price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.

Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering

Consumables

Services

Software

Split by manufacturers, this report focuses on the production, price of each type, average price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering

Roche

Dako (Agilent Technologies)

Merck

Abbott

Genesys Biolabs

(20/20GeneSystems)

Affymetrix

Agendia

ALMAC

Arrayit

Biocartic

BG Medicine

KEGG EXPRESSION Database

Thermo Fisher

BGI

Other

Split by applications, this report focuses on consumption and growth rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in each application, can be divided into

Oncology

Cardiology

Neurology

Others

Split by regions, this report focuses on the production, revenue, consumption and market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in these regions, from 2011 to 2020 (forecast), covering

USA

Japan

China

India

Southeast Asia

Table of Contents

Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Research Report to 2020

1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Overview and Price of Each Type

1.1 Product Overview and Scope of Commercializing Biomarkers in Therapeutic and Diagnostic Applications

1.2 Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Growth Rate 2011 to 2020

1.3 Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Growth Rate 2011 to 2020

1.4 Product Segments and Price of Each Type

1.4.1 Consumables and Price List (2015-2016)

1.4.2 Services and Price List (2015-2016)

1.4.3 Software and Price List (2015-2016)

1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016

1.5.1 Price List (Interviewed) of Consumables by Key Manufacturers

1.5.2 Price List (Interviewed) of Services by Key Manufacturers

1.5.3 Price List (Interviewed) of Software by Key Manufacturers

1.6 Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type in 2015

1.6.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type in 2015

1.6.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type in 2015

2 Global and China Market Competition Analysis by Manufacturers

2.1 Global Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue and Share List of Key Manufacturers 2015 to 2016

2.1.1 Global Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Share of Key Manufacturers 2015 to 2016

2.1.2 Global Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Share of Key Manufacturers 2015 to 2016

2.1.3 Global Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Average Price of Key Manufacturers 2015 to 2016

2.2 China Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue and Share of Key Manufacturers 2015 to 2016

2.2.1 China Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Share of Key Manufacturers 2015 to 2016

2.2.2 China Market Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Share of Key Manufacturers 2015 to 2016

2.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturing Base Distribution and Product Type of each Manufacturer

3 Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue and Growth Rate by Type

3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue and Growth Rate by Type (2011-2020)

3.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Market Share by Type (2011-2020)

3.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2011-2020)

3.1.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Type (2011-2020)

3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Growth Rate by Type (2011-2020)

3.2.1 Consumables Production and Production Growth Rate 2011-2020

3.2.2 Services Production and Production Growth Rate 2011-2020

3.2.3 Software Production and Production Growth Rate 2011-2020

3.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue and Growth Rate by Type (2011-2020)

3.3.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Market Share by Type (2011-2020)

3.3.4 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2011-2020)

3.3.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Type (2011-2020)

3.4 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Growth Rate by Type (2011-2020)

3.4.1 Consumables Production and Production Growth Rate 2011-2020

3.4.2 Services Production and Production Growth Rate 2011-2020

3.4.3 Software Production and Production Growth Rate 2011-2020

4 Global and China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Key Manufacturers Analysis

4.1 Roche

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Roche by Type

4.1.2.1 Consumables and Price in 2015 and 2016 of Roche

4.1.2.2 Services and Price in 2015 and 2016 of Roche

4.1.2.3 Software and Price in 2015 and 2016 of Roche

4.1.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Roche 2015 to 2016

4.1.4 Interviewee, Name and Contact

4.2 Dako (Agilent Technologies)

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Dako (Agilent Technologies) by Type

4.2.2.1 Consumables and Price in 2015 and 2016 of Dako (Agilent Technologies)

4.2.2.2 Services and Price in 2015 and 2016 of Dako (Agilent Technologies)

4.2.2.3 Software and Price in 2015 and 2016 of Dako (Agilent Technologies)

4.2.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Dako (Agilent Technologies) 2015 to 2016

4.2.4 Interviewee, Name and Contact

4.3 Merck

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Merck by Type

4.3.2.1 Consumables and Price in 2015 and 2016 of Merck

4.3.2.2 Services and Price in 2015 and 2016 of Merck

4.3.2.3 Software and Price in 2015 and 2016 of Merck

4.3.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Merck 2015 to 2016

4.3.4 Interviewee, Name and Contact

4.4 BD

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of BD by Type

4.4.2.1 Consumables and Price in 2015 and 2016 of BD

4.4.2.2 Services and Price in 2015 and 2016 of BD

4.4.2.3 Software and Price in 2015 and 2016 of BD

4.4.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of BD 2015 to 2016

4.4.4 Interviewee, Name and Contact

4.5 Abbott

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Abbott by Type

4.5.2.1 Consumables and Price in 2015 and 2016 of Abbott

4.5.2.2 Services and Price in 2015 and 2016 of Abbott

4.5.2.3 Software and Price in 2015 and 2016 of Abbott

4.5.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Abbott 2015 to 2016

4.5.4 Interviewee, Name and Contact

4.6 Genesys Biolabs

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Genesys Biolabs by Type

4.6.2.1 Consumables and Price in 2016 and 2016 of Genesys Biolabs

4.6.2.2 Services and Price in 2016 and 2016 of Genesys Biolabs

4.6.2.3 Software and Price in 2016 and 2016 of Genesys Biolabs

4.6.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Genesys Biolabs 2016 to 2016

4.6.4 Interviewee, Name and Contact

4.7 (20/20GeneSystems)

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of (20/20GeneSystems) by Type

4.7.2.1 Consumables and Price in 2017 and 2017 of (20/20GeneSystems)

4.7.2.2 Services and Price in 2017 and 2017 of (20/20GeneSystems)

4.7.2.3 Software and Price in 2017 and 2017 of (20/20GeneSystems)

4.7.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of (20/20GeneSystems) 2017 to 2017

4.7.4 Interviewee, Name and Contact

4.8 Affymetrix

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Affymetrix by Type

4.8.2.1 Consumables and Price in 2018 and 2018 of Affymetrix

4.8.2.2 Services and Price in 2018 and 2018 of Affymetrix

4.8.2.3 Software and Price in 2018 and 2018 of Affymetrix

4.8.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Affymetrix 2018 to 2018

4.8.4 Interviewee, Name and Contact

4.9 Agendia

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Agendia by Type

4.9.2.1 Consumables and Price in 2019 and 2019 of Agendia

4.9.2.2 Services and Price in 2019 and 2019 of Agendia

4.9.2.3 Software and Price in 2019 and 2019 of Agendia

4.9.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Agendia 2019 to 2019

4.9.4 Interviewee, Name and Contact

4.10 ALMAC

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of ALMAC by Type

4.10.2.1 Consumables and Price in 2020 and 2020 of ALMAC

4.10.2.2 Services and Price in 2020 and 2020 of ALMAC

4.10.2.3 Software and Price in 2020 and 2020 of ALMAC

4.10.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of ALMAC 2020 to 2020

4.10.4 Interviewee, Name and Contact

4.11 Arrayit

4.11.1 Company Basic Information, Manufacturing Base and Competitors

4.11.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Arrayit by Type

4.11.2.1 Consumables and Price in 2021 and 2021 of Arrayit

4.11.2.2 Services and Price in 2021 and 2021 of Arrayit

4.11.2.3 Software and Price in 2021 and 2021 of Arrayit

4.11.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Arrayit 2021 to 2021

4.11.4 Interviewee, Name and Contact

4.12 Biocartic

4.12.1 Company Basic Information, Manufacturing Base and Competitors

4.12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Biocartic by Type

4.12.2.1 Consumables and Price in 2022 and 2022 of Biocartic

4.12.2.2 Services and Price in 2022 and 2022 of Biocartic

4.12.2.3 Software and Price in 2022 and 2022 of Biocartic

4.12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Biocartic 2022 to 2022

4.12.4 Interviewee, Name and Contact

4.13 BG Medicine

4.13.1 Company Basic Information, Manufacturing Base and Competitors

4.13.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of BG Medicine by Type

4.13.2.1 Consumables and Price in 2023 and 2023 of BG Medicine

4.13.2.2 Services and Price in 2023 and 2023 of BG Medicine

4.13.2.3 Software and Price in 2023 and 2023 of BG Medicine

4.13.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of BG Medicine 2023 to 2023

4.13.4 Interviewee, Name and Contact

4.14 KEGG EXPRESSION Database

4.14.1 Company Basic Information, Manufacturing Base and Competitors

4.14.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of KEGG EXPRESSION Database by Type

4.14.2.1 Consumables and Price in 2024 and 2024 of KEGG EXPRESSION Database

4.14.2.2 Services and Price in 2024 and 2024 of KEGG EXPRESSION Database

4.14.2.3 Software and Price in 2024 and 2024 of KEGG EXPRESSION Database

4.14.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of KEGG EXPRESSION Database 2024 to 2024

4.14.4 Interviewee, Name and Contact

4.15 Thermo Fisher

4.15.1 Company Basic Information, Manufacturing Base and Competitors

4.15.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Thermo Fisher by Type

4.15.2.1 Consumables and Price in 2025 and 2025 of Thermo Fisher

4.15.2.2 Services and Price in 2025 and 2025 of Thermo Fisher

4.15.2.3 Software and Price in 2025 and 2025 of Thermo Fisher

4.15.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Thermo Fisher 2025 to 2025

4.15.4 Interviewee, Name and Contact

4.16 BGI

4.16.1 Company Basic Information, Manufacturing Base and Competitors

4.16.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of BGI by Type

4.16.2.1 Consumables and Price in 2026 and 2026 of BGI

4.16.2.2 Services and Price in 2026 and 2026 of BGI

4.16.2.3 Software and Price in 2026 and 2026 of BGI

4.16.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of BGI 2026 to 2026

4.16.4 Interviewee, Name and Contact

4.17 Other

4.17.1 Company Basic Information, Manufacturing Base and Competitors

4.17.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Segment of Other by Type

4.17.2.1 Consumables and Price in 2027 and 2027 of Other

4.17.2.2 Services and Price in 2027 and 2027 of Other

4.17.2.3 Software and Price in 2027 and 2027 of Other

4.17.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production, Revenue, Price of Other 2027 to 2027

4.17.4 Interviewee, Name and Contact

5 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production by Regions 2011-2020

5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue by Regions 2011-2020

5.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production by Regions 2011-2020

5.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions 2011-2020

5.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

5.3 USA Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

5.4 EU Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

5.5 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

5.6 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

5.7 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production and Revenue Growth Rate 2011-2020

6 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Regions 2011-2020

6.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Regions 2011-2020

6.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

6.3 USA Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

6.4 EU Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

6.5 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

6.6 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

6.7 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth Rate 2011-2020

7 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Analysis by Application and Client (Buyers)